HeartBeam Inc. to Discuss Q2 Results and Business Updates in August Conference Call

HeartBeam Inc. (NASDAQ: BEAT), a pioneer in medical technology aimed at revolutionizing cardiac care, has announced a conference call scheduled for August 13, 2025, at 4:30 p.m. Eastern Time. The call will focus on the company's second-quarter results for the period ending June 30, 2025, and will include updates on regulatory initiatives, commercial-readiness activities, and anticipated milestones. CEO Robert Eno and CFO Timothy Cruickshank will lead the discussion, offering insights into the company's performance and future directions, followed by a question-and-answer session.

The significance of this event lies in HeartBeam's innovative approach to cardiac care, particularly its development of the first-ever cable-free 12-lead ECG system. This technology is designed to capture the heart's electrical signals in three dimensions, enabling portable devices to deliver actionable heart intelligence outside traditional medical facilities. Such advancements could significantly impact the management of cardiac health, allowing for early detection and intervention of acute conditions. With 13 U.S. and 4 international patents, HeartBeam is at the forefront of redefining cardiac health management.

Investors and stakeholders interested in the latest developments can find more information in the company's newsroom at https://ibn.fm/BEAT. This conference call represents a critical opportunity for the company to showcase its achievements and outline its strategy for continued growth and innovation in the medical technology sector.